id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-2854-1167,FDA,FDA-2019-N-2854,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2023-02-14T05:00:00Z,2023,2,2023-02-14T05:00:00Z,,2023-02-14T14:58:21Z,2023-03073,0,0,090000648568b12a
FDA-2019-N-2854-1163,FDA,FDA-2019-N-2854,Reference 122 - Endotoxin and (1→3)-β-D-Glucan Contamination in Electronic Cigarette Products Sold in the United States,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:07:46Z,,0,0,09000064854f9609
FDA-2019-N-2854-1164,FDA,FDA-2019-N-2854,Reference 123 - Characterization of Bacterial Communities in Selected Smokeless Tobacco Products Using 16S rDNA Analysis,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:07:50Z,,0,0,09000064854f960a
FDA-2019-N-2854-1165,FDA,FDA-2019-N-2854,Reference 128 - Influence of Cigarette Filter Ventilation on Smokers’ Mouth Level Exposure to Tar and Nicotine,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:08:50Z,,0,0,09000064854f960b
FDA-2019-N-2854-1166,FDA,FDA-2019-N-2854,"Reference 140 - FDA Form 4057a, 2020",Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:09:07Z,,0,0,09000064854f960c
FDA-2019-N-2854-1161,FDA,FDA-2019-N-2854,Reference 111 - Differences in the Bacteriome of Smokeless Tobacco Products with Different Oral Carcinogenicity: Compositional and Predicted Functional Analysis,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:05:07Z,,0,0,09000064854f9607
FDA-2019-N-2854-1157,FDA,FDA-2019-N-2854,PMTA Rule Final Regulatory Impact Analysis,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:03:01Z,,0,0,09000064854f9500
FDA-2019-N-2854-1158,FDA,FDA-2019-N-2854,"Reference 10 – FDA Form 4057, 2020",Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:03:46Z,,0,0,09000064854f957d
FDA-2019-N-2854-1160,FDA,FDA-2019-N-2854,Reference 68 - Nicotine Absorption from Smokeless Tobacco Modified to Adjust pH,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:04:34Z,,0,0,09000064854f9606
FDA-2019-N-2854-1159,FDA,FDA-2019-N-2854,"Reference 11 – Form FDA 4057b, 2020",Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:03:54Z,,0,0,09000064854f9605
FDA-2019-N-2854-1162,FDA,FDA-2019-N-2854,Reference 114 - The Bacterial Communities of Little Cigars and Cigarillos Are Dynamic Over Time and Varying Storage Conditions,Supporting & Related Material,Background Material,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T21:05:56Z,,0,0,09000064854f9608
FDA-2019-N-2854-1156,FDA,FDA-2019-N-2854,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Tobacco Product Applications and Recordkeeping Requirements,Notice,30 Day Proposed Information Collection,2022-10-19T04:00:00Z,2022,10,2022-10-19T04:00:00Z,,2023-02-14T14:57:46Z,2022-22708,0,0,0900006485425c3b
FDA-2019-N-2854-1155,FDA,FDA-2019-N-2854,Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Tobacco Product Applications and Recordkeeping Requirements,Notice,60 Day Proposed Information Collection,2022-05-16T04:00:00Z,2022,5,2022-05-16T04:00:00Z,2022-07-16T03:59:59Z,2023-02-14T14:57:35Z,2022-10462,0,0,090000648507f038
FDA-2019-N-2854-1154,FDA,FDA-2019-N-2854,Agency Information Collection  Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2022-01-28T05:00:00Z,2022,1,2022-01-28T05:00:00Z,,2022-08-25T00:33:10Z,2022-01692,0,0,0900006484f3ec58
FDA-2019-N-2854-1148,FDA,FDA-2019-N-2854,Memorandum to FDA DMS on PMTA Final Rule (Docket No. FDA-2019-N-2854) re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:56:53Z,,0,0,0900006484dbe849
FDA-2019-N-2854-1152,FDA,FDA-2019-N-2854,TAB A 2020-242 PMTA Final Rule as Submitted to OMB re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:57:41Z,,0,0,0900006484dbe837
FDA-2019-N-2854-1150,FDA,FDA-2019-N-2854,TAB C 2020-242 PMTA Final Rule as Cleared by OMB re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:57:19Z,,0,0,0900006484dbeb4a
FDA-2019-N-2854-1153,FDA,FDA-2019-N-2854,TAB B 2020-242 PMTA Final Rule Track Changes re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:57:52Z,,0,0,0900006484dbe84b
FDA-2019-N-2854-1151,FDA,FDA-2019-N-2854,TAB C 2020-242 PMTA FRIA as Cleared by OMB re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:57:31Z,,0,0,0900006484dbeb4b
FDA-2019-N-2854-1149,FDA,FDA-2019-N-2854,TAB A 2020-242 PMTA FRIA as Submitted to OMB re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:57:02Z,,0,0,0900006484dbe84a
FDA-2019-N-2854-1147,FDA,FDA-2019-N-2854,"Premarket Tobacco Product Applications and Recordkeeping 
Requirements",Rule,Final Rule,2021-10-05T04:00:00Z,2021,10,2021-10-05T04:00:00Z,,2021-10-05T20:22:52Z,2021-21011,0,0,0900006484dba972
FDA-2019-N-2854-1146,FDA,FDA-2019-N-2854,Premarket Tobacco Product Applications and Recordkeeping Requirements; Reopening of the Comment Period,Proposed Rule,Extension of Comment Period,2020-03-10T04:00:00Z,2020,3,2020-03-10T04:00:00Z,2020-04-10T03:59:59Z,2020-03-10T12:24:41Z,2020-04828,0,0,090000648441fbd4
FDA-2019-N-2854-1144,FDA,FDA-2019-N-2854,Request for Extension of Comment Period from Thompson Hine,Other,Electronic Regulation from Form,2020-03-09T04:00:00Z,2020,3,2020-03-09T04:00:00Z,,2020-03-09T10:54:41Z,,0,0,0900006484181a11
FDA-2019-N-2854-1145,FDA,FDA-2019-N-2854,Unique Identifying Information for New Tobacco Products in a Grouped Submission of PMTAs,Supporting & Related Material,Background Material,2020-03-09T04:00:00Z,2020,3,,,2020-03-09T18:03:29Z,,0,0,0900006484409448
FDA-2019-N-2854-0664,FDA,FDA-2019-N-2854,Memorandum to FDA DMS on PMTA NPRM (Docket No. FDA-2019-N-2854),Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:05:51Z,,0,0,09000064841e7caf
FDA-2019-N-2854-0666,FDA,FDA-2019-N-2854,TAB A 2015-1093 PMTA PRIA as Submitted to OMB,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:08:25Z,,0,0,09000064841e7cb1
FDA-2019-N-2854-0667,FDA,FDA-2019-N-2854,TAB B 2015-1093 PMTA NPRM Track Changes,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:09:39Z,,0,0,09000064841e7cb2
FDA-2019-N-2854-0668,FDA,FDA-2019-N-2854,TAB B 2015-1093 PMTA PRIA Track Changes,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:10:24Z,,0,0,09000064841e7cb3
FDA-2019-N-2854-0670,FDA,FDA-2019-N-2854,TAB C 2015-1093 PMTA PRIA as Cleared by OMB,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:12:14Z,,0,0,09000064841e7cb6
FDA-2019-N-2854-0665,FDA,FDA-2019-N-2854,TAB A 2015-1093 PMTA NPRM as Submitted to OMB,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:07:26Z,,0,0,09000064841e7cb0
FDA-2019-N-2854-0669,FDA,FDA-2019-N-2854,TAB C 2015-1093 PMTA NPRM as Cleared by OMB,Supporting & Related Material,Background Material,2019-12-05T05:00:00Z,2019,12,,,2019-12-05T15:11:14Z,,0,0,09000064841e7cb5
FDA-2019-N-2854-0663,FDA,FDA-2019-N-2854,Premarket Tobacco Product Applications and Recordkeeping Requirements; Reopening of the Comment Period,Proposed Rule,Reopening of Comment Period,2019-11-26T05:00:00Z,2019,11,2019-11-26T05:00:00Z,2019-12-17T04:59:59Z,2019-12-18T02:01:22Z,2019-25675,0,0,09000064841b74c6
FDA-2019-N-2854-0303,FDA,FDA-2019-N-2854,Request for Extension of Comment Period,Other,Electronic Regulation from Form,2019-11-16T05:00:00Z,2019,11,2019-11-16T05:00:00Z,,2019-11-17T04:25:44Z,,0,0,0900006484164c39
FDA-2019-N-2854-0291,FDA,FDA-2019-N-2854,Request for Extension of the Comment Period,Other,Electronic Regulation from Form,2019-11-13T05:00:00Z,2019,11,2019-11-13T05:00:00Z,,2019-11-13T19:11:43Z,,0,0,090000648414df80
FDA-2019-N-2854-0285,FDA,FDA-2019-N-2854,Request for Extension of the Comment Period,Other,Request for Extension,2019-11-08T05:00:00Z,2019,11,2019-11-08T05:00:00Z,,2019-11-08T14:37:02Z,,0,0,090000648412bb4f
FDA-2019-N-2854-0283,FDA,FDA-2019-N-2854,Transcript 10-30-19 All Tribes Call Proposed PMTA Rule,Other,Transcript(s),2019-11-06T05:00:00Z,2019,11,2019-11-06T05:00:00Z,,2019-11-06T21:38:29Z,,0,0,0900006484126251
FDA-2019-N-2854-0003,FDA,FDA-2019-N-2854,"Reference 19 - Receptivity to Tobacco Advertising and Susceptibility to Tobacco Products, 2017",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:31Z,,0,0,0900006483fc810b
FDA-2019-N-2854-0031,FDA,FDA-2019-N-2854,"Reference 28 - IARC Working group on the Evaluation of Carcinogenic Risk to Humans, 2004",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:50Z,,0,0,0900006483fc81e2
FDA-2019-N-2854-0007,FDA,FDA-2019-N-2854,"Reference 15 - Exposure to Brand-Specific Cigarette Advertising in Magazines and its Impact on Youth Smoking, 1999",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:34Z,,0,0,0900006483fc78c9
FDA-2019-N-2854-0067,FDA,FDA-2019-N-2854,"Reference 63 - Design and Validation of a Research-Grade Waterpipe, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:51Z,,0,0,0900006483fc8fc9
FDA-2019-N-2854-0094,FDA,FDA-2019-N-2854,"Reference 85 - The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems, 2012",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:09Z,,0,0,0900006483fc94be
FDA-2019-N-2854-0090,FDA,FDA-2019-N-2854,"Reference 89 - Characteristics and Toxicant Emissions of JUUL electronic cigarettes, 2019",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:07Z,,0,0,0900006483fc94c2
FDA-2019-N-2854-0101,FDA,FDA-2019-N-2854,"Reference 95 - pH Changes in Smokeless Tobaccos Undergoing Nitrosation During Prolonged Storage, 1993",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:43Z,,0,0,0900006483fc9bcb
FDA-2019-N-2854-0100,FDA,FDA-2019-N-2854,"Reference 98 - Microbial Community Structure and Dynamics of Dark Fire-Cured Tobacco Fermentation, 2007",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:42Z,,0,0,0900006483fc9bce
FDA-2019-N-2854-0022,FDA,FDA-2019-N-2854,"Reference 35 - Trends in Nicotine Yield in Smoke and its Relationship with Design Characteristics, 2007",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:44Z,,0,0,0900006483fc7dd4
FDA-2019-N-2854-0019,FDA,FDA-2019-N-2854,"Reference 38 - Tobacco Cigarettes and Cigarette Smoke - An Overview, 2007",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:42Z,,0,0,0900006483fc7e0a
FDA-2019-N-2854-0018,FDA,FDA-2019-N-2854,"Reference 39 - The Changing Cigarette Chemical Studies and Bioassays, 2001",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:41Z,,0,0,0900006483fc7e0b
FDA-2019-N-2854-0057,FDA,FDA-2019-N-2854,"Reference 45 -  The Scientific Basis of Tobacco Product Regulation, 2007",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:44Z,,0,0,0900006483fc844e
FDA-2019-N-2854-0051,FDA,FDA-2019-N-2854,"Reference 48 - How Do Different Cigarette Design Features Influence the Standard, 2008",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:39Z,,0,0,0900006483fc8451
FDA-2019-N-2854-0122,FDA,FDA-2019-N-2854,"PRIA Reference 1 - Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act Final Rule,2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:36:11Z,,0,0,0900006483fcd7a5
FDA-2019-N-2854-0013,FDA,FDA-2019-N-2854,"Reference 9 - Effects of Advertisements on Smokers' Interest in Trying E-Cigarettes, 2014",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:38Z,,0,0,0900006483fc6b6a
FDA-2019-N-2854-0010,FDA,FDA-2019-N-2854,"Reference 12 - Preventing Tobacco Use Among Youth and Young Adults A Report of the Surgeon General, 2012",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:36Z,,0,0,0900006483fc6b6f
FDA-2019-N-2854-0081,FDA,FDA-2019-N-2854,"Reference 107 - Nicotine Concentrations in Electronic Refill and Do-it-Yourself Fluids, 2015",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:01Z,,0,0,0900006483fc9d87
FDA-2019-N-2854-0043,FDA,FDA-2019-N-2854,"Reference 56 - Characterization of Tobacco Products - A Comparative Study of the Tar, Nicotine, and Carbon, 1985",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:34Z,,0,0,0900006483fc84b1
FDA-2019-N-2854-0042,FDA,FDA-2019-N-2854,"Reference 57 - Smoke of Cigarettes and Little Cigars, 1972",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:33Z,,0,0,0900006483fc84b2
FDA-2019-N-2854-0059,FDA,FDA-2019-N-2854,"Reference 71 - Strategies to Reduce Tin and Other Metals in Electronic Cigarette Aerosol, 2015",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:45Z,,0,0,0900006483fc8fd1
FDA-2019-N-2854-0053,FDA,FDA-2019-N-2854,"Reference 77 - Protocol Proposal for, and Evaluation of, Consistency in Nicotine Delivery, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:41Z,,0,0,0900006483fc9397
FDA-2019-N-2854-0052,FDA,FDA-2019-N-2854,"Reference 78 - Emissions from Electronic Cigarettes - Key Parameters Affecting the Release of Harmful Chemicals, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:40Z,,0,0,0900006483fc9398
FDA-2019-N-2854-0091,FDA,FDA-2019-N-2854,"Reference 88 - Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of Novel, 2018",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:07Z,,0,0,0900006483fc94c1
FDA-2019-N-2854-0002,FDA,FDA-2019-N-2854,"Reference 20 - Tobacco Promotion and the Initiation of Tobacco Use, 2006",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:31Z,,0,0,0900006483fc810c
FDA-2019-N-2854-0032,FDA,FDA-2019-N-2854,"Reference 27 - E-Cigarette Marketing Exposure is Associated with E-Cigarette Use Among US Youth, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:51Z,,0,0,0900006483fc81e1
FDA-2019-N-2854-0110,FDA,FDA-2019-N-2854,"Reference 43 - The Diffusion of Carbon Monoxide Out of Cigarettes, 1977",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:49Z,,0,0,0900006483fc844c
FDA-2019-N-2854-0046,FDA,FDA-2019-N-2854,"Reference 53 - Drug Dissolution - Significance of Physicochemical Properties and Physiological Conditions, 2013",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:36Z,,0,0,0900006483fc84ae
FDA-2019-N-2854-0045,FDA,FDA-2019-N-2854,"Reference 54 - The Health Consequences of Smoking - Nicotine Addiction, 1988",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:35Z,,0,0,0900006483fc84af
FDA-2019-N-2854-0056,FDA,FDA-2019-N-2854,"Reference 74 - Evaluation of Electronic Cigarette Topography and Estimation of Liquid Consumption, 2013",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:43Z,,0,0,0900006483fc9394
FDA-2019-N-2854-0088,FDA,FDA-2019-N-2854,"Reference 91 - A Literature Review of Aging and Fermentation of Tobacco, 1964",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:05Z,,0,0,0900006483fc94c4
FDA-2019-N-2854-0080,FDA,FDA-2019-N-2854,"Reference 99 - Effect of Storage Conditions on Nitrosated Acylated and Oxidized Alkaloid Derivatives, 1989",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:00Z,,0,0,0900006483fc9bcf
FDA-2019-N-2854-0011,FDA,FDA-2019-N-2854,"Reference 11 - FDA Form 4057, 2019",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:37Z,,0,0,0900006483fc6b6c
FDA-2019-N-2854-0009,FDA,FDA-2019-N-2854,"Reference 13 - Longitudinal Effects of Pro-Tobacco and Anti-Tobacco Messages on Adolescent Smoking Susceptibility, 2006",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:35Z,,0,0,0900006483fc6b70
FDA-2019-N-2854-0125,FDA,FDA-2019-N-2854,"PRIA Reference 4 - Deeming Tobacco Products - Final Regulatory Impact Analysis, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:38:42Z,,0,0,0900006483fcd7a8
FDA-2019-N-2854-0070,FDA,FDA-2019-N-2854,"Reference 118 - Preliminary Regulatory Impact Analysis; Initial Regulatory Flexibility Analysis, 2019",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:53Z,,0,0,0900006483fc9c8b
FDA-2019-N-2854-0117,FDA,FDA-2019-N-2854,"Reference 106 - Nicotine Levels and Presence of Selected Tobacco-Derived Toxins in Tobacco Flavoured, 2015",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:59Z,,0,0,0900006483fc9d86
FDA-2019-N-2854-0079,FDA,FDA-2019-N-2854,"Reference 109 - Role of Nicotine in Pharmacokinetics in Nicotine Addiction and Nicotine Replacement Therapy, 2003",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:59Z,,0,0,0900006483fc9d89
FDA-2019-N-2854-0006,FDA,FDA-2019-N-2854,"Reference 16 - The Role of Tobacco Advertising and Promotion in Smoking Initiation, 2001",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:33Z,,0,0,0900006483fc78ca
FDA-2019-N-2854-0012,FDA,FDA-2019-N-2854,"Reference 10 - Demand for Smokeless Tobacco - Role of Advertising, 2013",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:37Z,,0,0,0900006483fc6b6b
FDA-2019-N-2854-0076,FDA,FDA-2019-N-2854,"Reference 112 - The Health Consequences of Smoking - 50 Years of Progress, 2014",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:57Z,,0,0,0900006483fc9d8c
FDA-2019-N-2854-0040,FDA,FDA-2019-N-2854,"Reference 59 - Dependence of the Gas Phase Composition of Smoke on the Combustion Temperature of Tobacco Products, 1972",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:32Z,,0,0,0900006483fc84b4
FDA-2019-N-2854-0066,FDA,FDA-2019-N-2854,"Reference 64 - Charcoal Emissions as a Source of CO and Carcinogenic PAH in Mainstream Narghile Waterpope Smoke, 2008",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:51Z,,0,0,0900006483fc8fca
FDA-2019-N-2854-0064,FDA,FDA-2019-N-2854,"Reference 66 - Electronic Cigarettes - Product Characterization and Design Considerations, 2013",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:49Z,,0,0,0900006483fc8fcc
FDA-2019-N-2854-0062,FDA,FDA-2019-N-2854,"Reference 68 - Correlation of Volatile Carbonyl Yields Emitted by E-Cigarettes with the Temperature, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:48Z,,0,0,0900006483fc8fce
FDA-2019-N-2854-0107,FDA,FDA-2019-N-2854,"Reference 70 - Effects of User Puff Topography, Device Voltage, and Liquid Nicotine Concentration, 2015",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:47Z,,0,0,0900006483fc8fd0
FDA-2019-N-2854-0106,FDA,FDA-2019-N-2854,"Reference 73 - Effect of Variable Power Levels on the Yield of Total Aerosol Mass and Formation of Aldehydes, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:46Z,,0,0,0900006483fc9393
FDA-2019-N-2854-0103,FDA,FDA-2019-N-2854,"Reference 80 - In Vitro Particle Size Distributions in Electronic and Conventional Cigarette Aerosols, 2013",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:44Z,,0,0,0900006483fc939a
FDA-2019-N-2854-0098,FDA,FDA-2019-N-2854,"Reference 81 - The Impact of the PM2.5 on the Human Respiratory System, 2016",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:12Z,,0,0,0900006483fc939b
FDA-2019-N-2854-0097,FDA,FDA-2019-N-2854,"Reference 82 - Impact of Electronic Cigarettes on the Cardiovascular System, 2017",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:11Z,,0,0,0900006483fc939c
FDA-2019-N-2854-0085,FDA,FDA-2019-N-2854,"Reference 94 - Control and Use of Microbes in Tobacco Product Manufacturing, 1989",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:03Z,,0,0,0900006483fc9bca
FDA-2019-N-2854-0127,FDA,FDA-2019-N-2854,"PRIA Reference 6 - National Occupational Employment and Wage Estimates, 2018",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:42:54Z,,0,0,0900006483fcd7aa
FDA-2019-N-2854-0026,FDA,FDA-2019-N-2854,"Reference 33 - Cigarette Rod Length and Its Impact on Serum Cotinine and Urinary Total NNAL Levels, 2014",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:47Z,,0,0,0900006483fc7dd2
FDA-2019-N-2854-0111,FDA,FDA-2019-N-2854,"Reference 41 - Effect of Cigarette Paper on Smoke Yield and Composition, 1978",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:50Z,,0,0,0900006483fc7e0d
FDA-2019-N-2854-0084,FDA,FDA-2019-N-2854,"Reference 104 - Temporal Variations in Cigarette Tobacco Bacterial Community Composition, 2017",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:03Z,,0,0,0900006483fc9d84
FDA-2019-N-2854-0020,FDA,FDA-2019-N-2854,Reference 37 - Effect of Manufacturing Variables on Cigarette Smoke Composition,Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:42Z,,0,0,0900006483fc7e09
FDA-2019-N-2854-0050,FDA,FDA-2019-N-2854,"Reference 49 - Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems, 2010",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:38Z,,0,0,0900006483fc8452
FDA-2019-N-2854-0048,FDA,FDA-2019-N-2854,"Reference 51 - Oral Mucosal Drug Delivery Clinical Pharmacokinetics, 2002",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:37Z,,0,0,0900006483fc8454
FDA-2019-N-2854-0115,FDA,FDA-2019-N-2854,NPRM Reference List  re: Premarket Tobacco Product Applications and Recordkeeping Requirements,Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:53Z,,0,0,0900006483fc67a4
FDA-2019-N-2854-0023,FDA,FDA-2019-N-2854,"Reference 2 - Application, function, and effects of menthol in cigarettes a survey of tobacco industry documents, 2004",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:47:44Z,,0,0,0900006483fc6822
FDA-2019-N-2854-0075,FDA,FDA-2019-N-2854,"Reference 113 - Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014, 2017",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:57Z,,0,0,0900006483fc9c86
FDA-2019-N-2854-0068,FDA,FDA-2019-N-2854,"Reference 62 - Investigation of Mainstream Smoke Aerosol of the Argileh Waterpipe, 2003",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:48:52Z,,0,0,0900006483fc84b7
FDA-2019-N-2854-0095,FDA,FDA-2019-N-2854,"Reference 84 - Surveillance of Moist Snuff Total Nicotine, Moisture, pH, Un-Ionized Nicotine, 2008",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:10Z,,0,0,0900006483fc94bd
FDA-2019-N-2854-0102,FDA,FDA-2019-N-2854,"Reference 92 - Influence of Microorganisms-Fermentation- on the Chemistry of Tobacco 1979, 2012",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T16:05:44Z,,0,0,0900006483fc94c5
FDA-2019-N-2854-0083,FDA,FDA-2019-N-2854,"Reference 96 - The Water Content Water Activity Relationship of Cured Tobacco and Water Relations, 1990",Supporting & Related Material,Background Material,2019-09-26T04:00:00Z,2019,9,,,2019-09-26T15:49:02Z,,0,0,0900006483fc9bcc